Bellevue Group »

Moonlake Immunot shares owned by Bellevue Group

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $221k 4.4k 50.23

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Boston Scientific Corporation (BSX)
Intra Cellular Therapies (ITCI)
Moderna (MRNA)
Dex (DXCM)
Revolution Medicines (RVMD)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Macrogenics (MGNX)
Alnylam Pharmaceuticals (ALNY)
Incyte Corporation (INCY)

View all positions for Bellevue Group

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
FMR
venBio Select Advisor
Citadel Advisors
Adage Capital Partners GP
T. Rowe Price Associates
Holocene Advisors
Federated Investors
T. Rowe Price Investment Management
Alliancebernstein
Westfield Capital Management Company
Polar Capital Holdings
Fred Alger Management
Marshall Wace

View all funds holding Moonlake Immunot